Published in Women's Health Weekly, December 25th, 2003
According to a study from Canada, "daily subcutaneous (sc) injections of N-terminal analogs of PTH increase bone mass and decrease fractures in osteoporotic women. We investigated the efficacy and safety of human PTH-(1-84) (full-length PTH) in the treatment of postmenopausal osteoporosis in a double-blind, placebo-controlled study. The women (n=50-53/group) self-administered PTH (50, 75, or 100 microgram) or placebo by daily sc injection for 12 months."
"PTH treatment induced time- and dose-related increases in lumbar spine bone mineral density (BMD). The 100-microgram dose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.